The Firm is well equipped to cater to its clients in the Pharmaceutical, Healthcare, Medical Devices and
Lifesciences industry. Our members have extensive experience in advising clients in the healthcare sector
in connection with their proposed investments in India as well as regulatory issues pertaining to the
research and development, manufacturing, marketing and import of drugs, cosmetics and medical devices.
The Firm also routinely advises clients on regulatory, ethical and compliance issues pertaining to clinical
trials in India.
Apart from regular advisory and transactional ability, the Firm also specializes in regulatory areas
including obtaining the requisite registrations/ approvals and maintaining compliance thereafter. Members
of this highly specialized practice have worked on diverse nature of applications for registrations/
approvals including manufacturing site and product registrations, new product approvals, change
notifications, re-registrations of manufacturing site and product, import license for Indian agents/
importers/ subsidiaries of foreign manufacturers etc.
In addition, our industry experts advise clients on government and industry anti-kickback statutes and
guidelines relating to physician-patient and drug representative- physician interactions. Our members
have advised clients on anti-bribery and anti-corruption issues arising out of Indian (The Prevention of
Corruption Act, The Prevention of Money Laundering Act), US (The Foreign Corrupt Practices Act) and
UK (Bribery Act) legislations governing ethical business practices in the pharmaceutical and healthcare
sector.
The Firm actively monitors legislative and policy developments at a national and state level and advises
clients on specific actions needed to address potential threats with respect to new regulations and
formation of risk mitigation strategies having legal, ethical, policy and risk management considerations.